Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 USD | +2.68% | -4.75% | -4.45% |
Mar. 08 | Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 08 | Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562 | MT |
Financials (USD)
Sales 2024 * | 12.32M | Sales 2025 * | 48.56M | Capitalization | 212M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -19M | EV / Sales 2024 * | 17.2 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.36 x |
P/E ratio 2024 * |
-4.29
x | P/E ratio 2025 * |
-12.7
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.89% |
Latest transcript on Ovid Therapeutics Inc.
1 day | +2.68% | ||
1 week | -4.75% | ||
Current month | +0.88% | ||
1 month | +2.56% | ||
3 months | -17.29% | ||
6 months | -10.30% | ||
Current year | -4.45% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 18-12-31 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 17-06-13 |
Bart Friedman
BRD | Director/Board Member | 79 | 15-11-22 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.077 | +2.90% | 23 794 |
24-04-25 | 2.99 | -5.08% | 112,117 |
24-04-24 | 3.15 | -1.56% | 113,127 |
24-04-23 | 3.2 | +1.59% | 110,579 |
24-04-22 | 3.15 | -2.48% | 205,940 |
Delayed Quote Nasdaq, April 26, 2024 at 01:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.45% | 212M | |
-1.83% | 103B | |
+0.44% | 95.71B | |
+1.69% | 22.02B | |
-17.22% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.76% | 15.52B | |
+3.27% | 13.86B | |
+35.63% | 12.04B |
- Stock Market
- Equities
- OVID Stock